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The prevalence of IgE-mediated allergic dis-
eases such as asthma, hay fever, and atopic der-
matitis has increased dramatically over the past 
two decades, especially in industrialized coun-
tries (1). For example, the incidence of asthma 
has nearly doubled since 1980 in the United 
States as well as in Japan (1, 2).   However, the 
precise mechanisms underlying the increased 
incidence of allergic diseases are not fully un-
derstood. One possible explanation has been 
termed “the hygiene hypothesis,” which pro-
poses that improved hygiene combined with 
the excessive use of antibiotics in industrial 
countries has markedly reduced the incidence 
of infections, particularly in children. This lack 
of early exposure to infectious agents is associ-
ated with accelerated IgE production and an 
increased incidence of allergic disorders (1–3). 
Epidemiological studies support this hypoth-
esis (4–6), and bacterial and viral products have 
been proposed as therapeutic strategies to sup-
press the development of allergic responses. For 
example, vaccination with Mycobacterium bovis 
bacillus Calmette Guerin (BCG) has been re-
ported to suppress IgE production and inhibit 
the development of allergic diseases in mouse 
models (7–9) and in humans (10). Furthermore, 
injection of CpG oligodeoxynucleotides, bac-
terial DNA surrogates recognized by Toll-like 
receptor (TLR)9, reduces serum IgE levels in 
mice (11).
It has been widely accepted that IgE pro-
duction is totally dependent on Th2 cells, 
whose functions are reciprocally inhibited by 
Th1 cells. Mechanistically, therefore, the hy-
giene hypothesis is based on an imbalance in 
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Epidemiological studies have suggested that the recent increase in the incidence and 
  severity of immunoglobulin (Ig)E-mediated allergic disorders is inversely correlated with 
Mycobacterium bovis bacillus Calmette Guerin (BCG) vaccination; however, the underlying 
mechanisms remain uncertain. Here, we demonstrate that natural killer T (NKT) cells in 
mice and humans play a crucial role in the BCG-induced suppression of IgE responses. BCG-
activated murine V𝗂14 NKT cells, but not conventional CD4 T cells, selectively express high 
levels of interleukin (IL)-21, which preferentially induces apoptosis in B𝗆 cells. Signaling 
from the IL-21 receptor increases the formation of a complex between Bcl-2 and the 
proapoptotic molecule Bcl-2–modifying factor, resulting in B𝗆 cell apoptosis. Similarly, BCG 
vaccination induces IL-21 expression by human peripheral blood mononuclear cells (PBMCs) 
in a partially NKT cell–dependent fashion. BCG-activated PBMCs signifi  cantly reduce IgE 
production by human B cells. These fi  ndings provide new insight into the therapeutic effect 
of BCG in allergic diseases.
CORRESPONDENCE
Masaru Taniguchi: 
taniguti@rcai.riken.jp
Abbreviations used: α-GalCer, 
α-galactosylceramide; BCG, 
Mycobacterium bovis bacillus 
Calmette Guerin; BM-DC, 
BM-derived DC; Bmf, Bcl-2–
modifying factor; γc, common 
γ-chain; IRAK, IL-1R–
associated kinase; MNC, 
mononuclear cell; MyD88, 
myeloid diff  erentiation factor 
88; PGN, peptidoglycan; TLR, 
Toll-like receptor.
The online version of this article contains supplemental material.2930  IL-21–DEPENDENT Bε CELL APOPTOSIS MEDIATED BY NKT CELLS | Harada et al.
the Th1/Th2 ratio because bacterial components stimulate 
Th1 responses that in turn inhibit Th2 responses and IgE 
production (12). On the other hand, recent fi  ndings have in-
dicated that a spectrum of T cells with immunoregulatory 
properties is involved in the regulation of IgE production and 
the pathophysiology of allergic diseases (13). For example, 
CD4+CD25+ regulatory T cells inhibit Th2 responses by 
producing immunosuppressive cytokines that can directly in-
hibit B cell activation (14, 15). Furthermore, NKT cells ex-
pressing an invariant antigen receptor (Vα14-Jα281 for mice 
and Vα24-JαQ for humans; reference 16) suppress Th2 and 
IgE responses via their production of IFN-γ (17).
In addition to these cellular mechanisms, it has also been 
reported that IL-21 is involved in the suppression of IgE pro-
duction in both mice and humans (18, 19). IL-21 is a type I 
cytokine produced by activated CD4+ T cells and has a broad 
capacity to regulate lymphoid cell functions (20–22). Among 
these functions, IL-21 directly inhibits antibody production 
by IgE-bearing B (Bε) cells induced by CD40L and IL-4 
(18). Conversely, IL-21R–defi  cient mice exhibit enhanced 
IgE production (23). IL-21 has been shown to specifi  cally in-
hibit germ line transcription of the IgE constant region (Cε) 
gene but not of other isotype genes (18). However, there is 
no direct evidence that this inhibition of germ line transcrip-
tion is responsible for the suppression of IgE production, as 
class switch recombination of Ig genes and subsequent anti-
body secretion are diff  erentially regulated events (24). IL-21 
also induces apoptosis in B cells (25, 26), which could par-
tially explain the reduction of IgE production; however, this 
eff   ect was not shown to be specifi   c for IgE. Hence, the 
mechanism by which IL-21 specifi  cally inhibits IgE produc-
tion is not yet fully understood.
Here, we have investigated BCG-mediated IgE suppres-
sion and found that NKT cells specifi  cally induced apoptosis 
in Bε cells through the production of IL-21, resulting in a 
dramatic decrease in IgE production. IL-21 increased the for-
mation of a complex between Bcl-2 and the proapoptotic 
molecule Bcl-2–modifying factor (Bmf), which is selectively 
expressed in Bε cells and counteracts the antiapoptotic activ-
ity of Bcl-2. We have found that similar mechanisms are op-
erative in humans. This is the fi  rst report demonstrating that 
IL-21 produced by Vα14 NKT cells plays an important role 
in the regulation of IgE responses in both mouse and human 
immune systems.
RESULTS
V𝗂14 NKT cell–dependent IgE suppression by BCG treatment
We used an OVA-patched sensitization protocol (27) to de-
termine if BCG activates Vα14 NKT cells. Vα14 NKT cells 
were detected by α-galactosylceramide (α-GalCer)–loaded 
CD1d tetramer staining. In control mice treated with PBS or 
OVA without BCG,  15% of the liver mononuclear cells 
(MNCs) were Vα14 NKT cells (Fig. 1 A, left and middle). 
However, BCG treatment signifi   cantly increased the fre-
quency of Vα14 NKT cells to >25% (Fig. 1 A, right). BCG 
treatment also increased the absolute number of Vα14 NKT 
cells because the total number of liver MNCs was also in-
creased by 50–80% (not depicted). Sera were collected from 
these mice 1 wk after the last sensitization, and IgE levels 
were evaluated. In WT mice, both total and OVA-specifi  c 
IgE levels were suppressed by BCG treatment (Fig. 1 B). In 
mice lacking the Jα18 gene (Vα14 NKT KO), there was no 
signifi  cant BCG-induced suppression of IgE responses, sug-
gesting that suppression requires Vα14 NKT cells.
The effect of BCG administration on Th1/Th2 responses
It is well known that the isotype commitment of B cells dur-
ing Ig class switching is tightly regulated by Th1/Th2 cell 
cytokines (28) and that Vα14 NKT cells play a regulatory 
role in T cell diff  erentiation (17, 29, 30). Therefore, we mea-
sured serum IgG2a (Th1) and IgG1 (Th2) levels to assess any 
changes in the Th1/Th2 balance. BCG administration did 
Figure 1.  Requirement of V𝗂14 NKT cells in BCG-mediated IgE 
suppression. (A) FACS profi  les of liver MNCs. The liver MNCs obtained 
1 wk after the last immunization were stained with α-GalCer/CD1d tetra-
mer and anti-TCRβ mAb. Three mice per each group were analyzed and 
representative data are shown. (B and C) Effects of BCG on antibody re-
sponses in WT and Vα14 NKT KO mice. Total and OVA-specifi  c serum IgE (B), 
IgG1, and IgG2a (C) were assayed by ELISA. Five mice were used in each 
group. Values are expressed as mean ± SD. The asterisks (*) indicate that 
the amount of IgE was below the detection level for anti-OVA IgE (<31.2 
U/ml), anti-OVA IgG1 (<0.002 U/ml), or anti-OVA IgG2a (<1.25 U/ml). N.S., 
not significant. All experiments were repeated three times with 
similar results.JEM VOL. 203, December 25, 2006  2931
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not signifi  cantly alter the levels of OVA-specifi  c IgG1 or 
IgG2a, although total levels of both isotypes were  signifi  cantly 
enhanced (Fig. 1 C).
Innate signaling pathway for BCG-mediated 
IL-12 production
During microbial infection, both CD1d- and IL-12– mediated 
signals are required for the rapid activation of Vα14 NKT 
cells (31). Thus, we assessed IL-12 production after BCG 
treatment. BM-derived DCs (BM-DCs) were stimulated in 
vitro with 50 μg/ml BCG and examined for IL-12 production 
by intracellular cytokine staining using an IL-12p40/p70 mAb. 
Upon BCG stimulation, a large fraction of CD11chigh cells 
produced IL-12 (Fig. 2 A). NF-κB activation is crucial for 
IL-12 production, and BCG treatment activated NF-κB to 
the same extent as treatment with the positive control CpG, 
as demonstrated by electrophoretic mobility shift assay (Fig. 
2 B). These results indicate that BCG directly induces IL-12 
production in DCs by activating NF-κB.
It has been reported that mycobacterial cell wall antigens 
such as peptidoglycan (PGN) or lipoarabinomannan induce 
proinfl  ammatory gene transcription through TLR2 and TLR4 
(32). However, when we compared IL-12p70 production by 
BCG-stimulated WT and TLR2/TLR4 double KO BM-DCs, 
there was no diff  erence (Fig. 2 C). As expected, however, the 
TLR2/4-defi  cient cells failed to respond to LPS or PGN 
(Fig. 2 D). These results indicate that receptor(s) other than 
TLR2 and TLR4 are responsible for the recognition of whole 
BCG organisms.
To analyze intracellular signaling pathways activated by 
BCG, we measured IL-12p70 production by BM-DCs 
from WT and IL-1R–associated kinase (IRAK)-4 KO mice. 
BM-DCs from IRAK-4 KO mice produced less IL-12p70 
than those from WT mice in response to both BCG and 
CpG (Fig. 2 E), whereas they produced comparable levels 
of IL-6 in response to TNF-α stimulation (Fig. 2 F). Simi-
larly, BM-DCs from myeloid diff   erentiation factor 88 
(MyD88) KO mice produced nearly undetectable IL-12p70 
upon BCG stimulation, whereas IL-6 production remained 
unchanged (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20062206/DC1). Therefore, the recogni-
tion of BCG organisms is mediated by innate receptors 
other than TLR2 and TLR4 that signal through both IRAK-4 
and MyD88.
Figure 2.  Activation of DCs by BCG. IL-12 production (A) and NF-κB 
activation (B). (A) Intracellular staining of BM-DCs with anti–IL-12p40/p70 
and anti-CD11c mAbs with or without in vitro BCG (50 μg/ml) treatment 
for 12 h. BCG-treated BM-DCs (10,000 cells) were analyzed by FACS, 
and the number in each panel indicates the percentage of total cells. 
(B) NF-κB activation. 2 × 105 BM-DCs were stimulated with or without 
50 μg/ml BCG or 1 μM CpG in vitro. NF-κB activity was determined by 
EMSA. (C and D) No requirement of TLR2 and TLR4 in BCG-mediated IL-12 
production. 2 × 105 BM-DCs derived from WT (C) or TLR2/4 double KO (D) 
mice were stimulated in vitro with or without 10 μg/ml LPS, 10 μg/ml 
PGN, or 150 μg/ml BCG for 48 h, and IL-12p70 levels were measured by 
ELISA. (E and F) Requirement of IRAK-4 for IL-12 production. 2 × 105 BM-
DCs were assayed for IL-12p70 by ELISA after stimulation with 0, 50, or 
150 μg/ml BCG or 1 μM CpG (E), and for IL-6 with 10 ng/ml TNF-α 
  stimulation for 48 h (F). In C–F, values are expressed as mean ± SD of 
triplicate cultures. The asterisks (*) indicate that the levels were below the 
detection limits for IL-12p70 (<62.5 pg/ml) and IL-6 (<15.6 pg/ml). N.S., 
not signifi  cant. All experiments were repeated twice with similar results.
Figure 3.  IL-21 expression. (A) Vα14 NKT cell–dependent IL-21 pro-
duction. Liver MNCs were obtained after BCG injection (500 μg/mouse) 
and examined for IL-21 mRNA expression. (B) Identifi  cation of the 
source of IL-21. Vα14 NKT and conventional T cells were sorted from 
liver MNCs and examined for IL-21 mRNA expression. (C) Requirement 
of DCs for BCG-induced IL-21 expression by Vα14 NKT cells. Liver 
TCRβ+ cells were cultivated in the presence of 50 μg/ml BCG with 
(top) or without (bottom) BM-DCs for 24 h and analyzed for IL-21 
mRNA expression. Liver TCRβ+ cells stimulated with 10 μg/ml anti-CD3 
mAb were used as a positive (Pos.) control. (D) Requirement of IL-12– 
and CD1d-mediated signals for IL-21 mRNA expression upon BCG 
stimulation. An isotype control, anti–IL-12p40/p70, or anti-CD1d 
mAb (20 μg/ml) was added to the cultures of liver TCRβ+ cells and 
BM-DCs as described in C. All experiments were repeated twice with 
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BCG-induced IL-21 expression in V𝗂14 NKT cells
The recently identifi   ed IL-21 and its receptor (IL-21R), 
members of the common γ-chain (γc)-dependent cytokine 
family, have been shown to regulate IgE production without 
infl  uencing Th2 cell diff  erentiation (18, 20, 23). Thus, we 
examined the possibility that IL-21 might be induced by 
BCG stimulation and might suppress IgE responses in a Vα14 
NKT cell–dependent manner. We fi   rst measured IL-21 
mRNA expression in TCRβ+ liver MNCs by a RT-PCR. 
IL-21 mRNA was detected in liver TCRβ+ liver MNCs of 
WT mice within 6 h after BCG injection (Fig. 3 A). In con-
trast, no IL-21 mRNA was detected in the Vα14 NKT KO 
mice (Fig. 3 A), suggesting that Vα14 NKT cells are the 
source of IL-21 in response to BCG. To test this hypothesis, 
we separated conventional T cells and Vα14 NKT cells and 
found that IL-21 mRNA was more abundant in the Vα14 
NKT cells after BCG injection (Fig. 3 B). Similarly, after 
stimulation with anti-CD3, IL-21 mRNA levels in Vα14 
NKT cells were more than seven times higher than in CD4 
T cells, confi  rming that these cells are the major source of 
IL-21 in this model (Fig. S2 A, available at http://www.jem.
org/cgi/content/full/jem.20062206/DC1).
Requirement for IL-12 and CD1d in IL-21 expression 
by V𝗂14 NKT cells
We next analyzed the role of DCs in BCG-induced IL-21 
mRNA expression. Co-culture of Vα14 NKT cells with 
DCs plus IL-12 strongly induced IL-21 mRNA expression, 
whereas no IL-21 mRNA was induced in the absence of DCs 
(Fig. 3 C). Furthermore, IL-21 mRNA expression was inhib-
ited by the addition of anti–IL-12, anti-CD1d, or both into 
the cultures (Fig. 3 D), indicating that both IL-12 and CD1d 
are required for IL-21 expression by Vα14 NKT cells.
IL-21–mediated IgE suppression
To examine whether BCG-activated Vα14 NKT cells actu-
ally suppress IgE production, Bε cells were generated from 
naive CD19+ splenic B cells using the 3-d culture system 
  described by Snapper et al. (33). The starting population of 
  naive B cells expressed negligible IL-21R and contained no 
Bε cells as defi  ned by Cε transcripts (Fig. 4 A). However, after 
3 d of the culture, the majority of CD19+ B cells became Bε 
cells and expressed IL-21R (Fig. 4 A). We then investigated 
the eff  ects of BCG treatment on B cells, before and after IgE 
class switching. The addition of BCG-treated liver MNCs at 
the onset of the naive B cell cultures signifi  cantly suppressed 
IgE production ( 50%; Fig. 4 B). However, when BCG-
  activated Vα14 NKT cells were added to the Bε cell culture on 
day 3 and the cells were further cultivated for 5 d, IgE pro-
duction was even more strongly inhibited (>90% suppres-
sion; Fig. 4 C). These results indicate that, even after B cells 
have undergone Cε class switching, BCG-activated Vα14 
NKT cells can potently suppress IgE production. The inhibi-
tion of IgE production was IL-21 dependent, as an anti–IL-21 
mAb completely abrogated the inhibitory eff  ects (Fig. 4, B 
and C). When the B cells in these cultures were assessed for 
apoptosis by annexin V staining, there was a signifi  cant increase 
Figure 4.  IL-21–mediated B𝗆 cell apoptosis. (A) RT-PCR analysis. 
Expression of IgE (Cε), IL-21R, and γc was investigated in naive B (left) 
and Bε (right) cells. (B) Suppression of IgE production in naive B cell cul-
tures. Naive B cells and Vα14 NKT cells (105 each) were cocultured in the 
presence of sCD40L and IL-4. (C) Suppression of IgE production in the Bε 
cell culture. 105 Vα14 NKT cells were added to the Bε cell (105) cultures. In 
B and C, 20 μg/ml anti–IL-21 mAb or isotype control mAb was added at 
the same time as the Vα14 NKT cells. The concentration of total IgE was 
measured by ELISA in triplicate. Values are expressed as mean ± SD. N.S., 
not signifi  cant. The experiments were repeated three times with similar 
results. (D) IL-21–mediated Bε cell apoptosis. 2 × 105 Bε and Bγ cells 
were generated and then further cultured with or without 30 ng/ml IL-21 
for 30 h. Annexin V staining was then performed. The numbers represent 
percentage of the gated cells. Annexin V+ cells among Bε and Bγ cells 
just before IL-21 treatment was 25.7 and 29.2%, respectively (not depicted). 
The experiments were repeated three times with similar results.
Figure 5.  Bmf-mediated B𝗆 cell apoptosis. (A) RT-PCR. RNA from 
Bε and Bγ cells was analyzed for its expression of the indicated genes 
by RT-PCR. Note that no signifi  cant differences in Bcl-2 and IL-21R 
expression between Bε and Bγ cells were observed. (B) Western blotting. 
Bε cells were stimulated with IL-21 at 37°C for 30 min, and their 
cell lysates (6 × 106) were subjected to immunoprecipitation with 
anti–Bcl-2 mAb and immunoblotting with anti-Bmf antibody (top) or 
anti–Bcl-2 mAb (bottom). All experiments were repeated three times 
with similar results.JEM VOL. 203, December 25, 2006  2933
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in apoptotic Bε cells that was not observed in the Bγ cells 
(Fig. 4 D, middle). Apoptosis of Bε cells was abrogated by 
the addition of anti–IL-21, a treatment that had no signifi  cant 
eff  ect on Bγ cells (Fig. 4 D, right).
Bmf-induced B𝗆 cell apoptosis
To understand the molecular mechanisms underlying IL-21–
induced IgE suppression, we performed DNA   microarray 
analyses to compare gene expression between Bε and Bγ 
cells. The DNA microarray data were deposited in the 
Center for Information Biology Gene Expression database 
(CIBEX; http://cibex.nig.ac.jp/) under accession number 
CBX15. The proapoptotic Bmf gene (34) was dramatically 
up-regulated in Bε cells, a fi  nding that was confi  rmed by 
RT-PCR (Fig. 5 A). No signifi  cant diff  erence in the ex-
pression of IL-21R, Bcl-2, or γc was detected (Fig. 5 A), 
suggesting that elevated Bmf gene expression in Bε, but not 
in Bγ, cells may account for their diff  erential sensitivity to 
IL-21–mediated apoptosis.
To investigate whether the Bmf expressed in Bε cells is 
functional in its proapoptotic activity, Bmf cDNA was iso-
lated from Bε cells and used to prepare several mutants of en-
hanced GFP–fused Bmf. These mutations included an A69P 
mutation in the dynein light chain 2 binding motif and an 
L138A mutation in the BH3 domain. These Bmf mutants 
were transfected into Baf3 cells. Upon IL-3 deprivation, 
mock transfectants underwent apoptosis. Transfection with 
WT Bmf or Bmf-A69P to Baf3 cells also signifi  cantly aug-
mented apoptosis (Fig. S3, available at http://www.jem.org/
cgi/content/full/jem.20062206/DC1). However, reduced 
apoptosis was seen in Baf3 cells transfected with BH3 mu-
tants, such as Bmf-L138A or Bmf-A69P/L138A (Fig. S3), 
indicating that Bmf in Bε cells is functional and the BH3 
domain of the protein is important for mediating its proapop-
totic activity.
Based on the understanding of proapoptotic activity of 
Bmf expressed in Bε cells, we investigated the formation of 
Bmf–Bcl-2 complexes in Bε cells after activation with IL-21. 
Bmf in Bε cells faintly binds to Bcl-2 in unstimulated cells 
(Fig. 5 B, left). However, when Bε cells were stimulated 
with IL-21, the formation of Bmf–Bcl-2 complexes was sig-
nifi  cantly augmented (Fig. 5 B, right).
BCG-mediated IL-21 induction in human V𝗂24 NKT cells
To determine how widespread our fi  ndings are, we investi-
gated whether IL-21 and Vα24 NKT cells are required for 
the BCG-mediated suppression of human IgE responses. 
When human PBMCs were stimulated with α-GalCer or 
BCG, a signifi  cant up-regulation of IL-21 mRNA was de-
tected by quantitative PCR (Fig. 6 A). The BCG-induced 
up-regulation of IL-21 mRNA was eff  ectively suppressed by 
blocking with antibodies against CD1d, IL-12p40/p70, or 
both (Fig. 6 B), indicating that the CD1d-restricted NKT 
cell–dependent suppression of IgE responses observed in 
mice also operates in the human immune system. IL-21 
mRNA expression by anti-CD1d and anti–IL-12 treatment 
was signifi  cantly reduced but was not as eff  ective as in the 
mouse Vα14 NKT cell system (Fig. 3 D), perhaps suggesting 
a signifi  cant contribution of human conventional CD4+ T 
cells (Fig. S2 B).
To evaluate in vivo responses, we inoculated BCG into 
healthy volunteers and examined IL-21 mRNA levels in 
PBMCs 1 wk later. There was a signifi  cant up-regulation of 
IL-21 mRNA levels in fi  ve out of six individuals (Fig. 6 C), 
and, furthermore, IL-21 suppressed IgE production by  human 
Bε cells (Fig. 6 D, left). As expected, the addition of BCG-
stimulated, but not control, PBMCs signifi  cantly inhibited 
IgE production (Fig. 6 D, right).
Figure 6.  IL-21 mRNA expression and IL-21–induced IgE suppression 
in humans. (A) IL-21 mRNA expression in PBMCs. 106 human PBMCs 
were stimulated with 100 ng/ml α-GalCer or 50 μg/ml BCG and 
examined for IL-21 expression by quantitative real-time PCR with 
  Taqman probes. The data are representative of fi  ve donors. (B) IL-12 and 
CD1d are required for IL-21 expression. 106 PBMCs were stimulated in 
vitro with 50 μg/ml BCG in the presence of 10 μg/ml anti-CD1d and/or 
anti–IL-12p40/p70 mAb. Representative data from fi  ve donors are 
shown. (C) IL-21 mRNA expression in PBMCs. Healthy volunteers were 
inoculated intradermally with BCG (two drops of 26.7 mg/ml of BCG 
emulsion per person). In A–C, the data for IL-21 expression were nor-
malized to 18S ribosomal RNA expression, and relative expression levels 
are shown. Statistical analysis was performed using a matched pairs 
t test in C. (D) Suppression of IgE production. Left, suppression of IgE 
production by IL-21. 2 × 105 human B cells were cultured with sCD40L 
and IL-4 in the presence of human IL-21 for 14 d. Right, suppression of 
IgE production by BCG-activated human PBMCs. 105 Bε cells were co-
cultured with 105 PBMCs, sCD40L, and IL-4 in the presence of 50 μg/ml 
BCG for 14 d. Total IgE was measured by ELISA. Values are expressed as 
mean ± SD of triplicate cultures. The asterisks (*) indicate that the IgE 
levels are below the detection limit for total IgE (<0.014 IU/ml). Data 
shown are representative of three donors. Results were expressed as a 
fold difference in human IL-21 gene expression relative to a control 
sample (vehicle) after being normalized with 18S ribosomal RNA expres-
sions in each sample.2934  IL-21–DEPENDENT Bε CELL APOPTOSIS MEDIATED BY NKT CELLS | Harada et al.
DISCUSSION
It is widely accepted that the mechanistic basis of the hygiene 
hypothesis for suppression of IgE responses is an increase in 
the Th1/Th2 ratio (12). However, in reality, the Th1 response 
exacerbates allergic reactions, as human asthma is associated 
with the production of IFN-γ, a cytokine that appears to 
contribute to the pathogenesis of the disease (35). Furthermore, 
the adoptive transfer of allergen-specifi  c Th1 cells causes se-
vere airway infl  ammation (36). Thus, a shift in the Th1/Th2 
ratio alone cannot explain all of the immunological fi  ndings 
observed in allergic diseases (1). Furthermore, there are sev-
eral studies suggesting that BCG vaccination has little or no 
eff  ect on the development and prevalence of allergic diseases 
(37, 38). Therefore, it is necessary to better understand the 
precise mechanism of IgE suppression in BCG-treated ani-
mals or humans.
In this study, neither a Th1/Th2 imbalance nor an in-
volvement of regulatory T cells was observed in response to 
BCG treatment (Fig. 1). Instead, we demonstrated that IL-
21–induced Bε cell apoptosis is the mechanism responsible 
for BCG-mediated suppression of IgE production (Figs. 1, 3, 
and 5). Because the human IL-21 responses to BCG vaccina-
tion were heterogeneous (Fig. 6 C), it seems likely that the 
magnitude of the response in each individual could cause dif-
ferent degrees of BCG-induced IgE suppression and might 
be prognostic.
Previous studies have indicated that IL-21 is preferentially 
expressed by activated CD4+ T cells (20), the results that are 
partially in agreement with the present data, as half of periph-
eral Vα14 NKT cells are CD4+ (39, 40). Interestingly, upon 
anti-CD3 mAb stimulation, Vα14 NKT cells, but not con-
ventional T cells, preferentially expressed IL-21 (Fig. S2 A), 
similar to the results with BCG (Fig. 3 B). Therefore, the 
major IL-21 producers in response to BCG in mice are Vα14 
NKT cells.
It has been proposed that, for full activation of Vα14 NKT 
cells to produce IFN-γ, two signals are required: one CD1d-
dependent and the other TLR-mediated IL-12–dependent 
signals (31). In agreement with this, IL-21 expression by 
BCG-activated Vα14 NKT cells was signifi  cantly inhibited 
by blocking with antibodies to IL-12 and/or CD1d (Fig. 3 D). 
Therefore, it is likely that Vα14 NKT cells recognize endo-
genous antigens presented by CD1d molecules but require 
IL-12 signals to produce IL-21. Nevertheless, it is still possible 
that glycolipid BCG components such as phosphatidylinositol 
mannoside may directly stimulate Vα14 NKT cells to pro-
duce IL-21 in a CD1d-dependent manner (41, 42).
In terms of the receptors on DCs that are required for 
BCG recognition and signal transduction, we showed in this 
study that BCG-induced IL-12 production is IRAK-4 and 
MyD88 dependent (Fig. 2 E and Fig. S1). These results in 
mice are consistent with a recent report indicating that BCG 
cannot induce IL-12 or IFN-γ production by PBMCs from 
IRAK-4–defi  cient patients (43). In addition, it has been 
  reported that BCG enhances NF-κB–dependent gene trans-
cription through the activation of phosphatidylinositol 3 ki-
nase and c-Jun N-terminal kinase cascades (44). The activated 
NF-κB is then liberated for nuclear translocation and transac-
tivates a variety of immune response genes, including IL-12.
In contrast to a previous report that implicated TLR2 and 
TLR4 in the recognition of mycobacterial antigens (32), we 
could not identify any involvement of these receptors in IL-12 
production by BCG-stimulated BM-DCs (Fig. 2, C and D). 
In agreement with our fi  ndings, it has recently been reported 
that TLR2/4 double KO mice infected with live BCG have 
normal adaptive immune responses and survived as long as 
WT mice (45). As whole BCG contains multiple   components 
including mycobacterial glycolipids, proteins, and DNA, 
several receptors that use IRAK-4 and MyD88 as the signal 
transducer appear to be involved in the complex recognition 
of BCG.
In IL-21R–defi  cient mice, the level of circulating IgE is 
high, whereas that of IgG1 is low (23, 46). Similarly, in hu-
man B cells, IL-21 inhibits IgE production and stimulates 
IgG4 (analogous to mouse IgG1) production (19). These re-
sults suggest that IL-21 diff  erentially regulates IgE and IgG1 
(IgG4 in humans) class switching. In fact, Suto et al. (18) re-
ported that IL-21 specifi  cally suppresses IgE production by 
inhibiting germ line Cε transcripts. Our present fi  ndings do 
not exclude this possibility. IL-21 has also been reported to 
induce apoptosis in resting and activated B cells by reducing 
the expression levels of apoptosis-related genes (25, 26). 
However, in this report, we have shown that IL-21 selec-
tively induces apoptosis in Bε, but not Bγ, cells (Fig. 4 D). 
Thus, our fi   ndings that BCG-activated IL-21–expressing 
Vα14 NKT cells suppressed IgE production even after class 
switching (Fig. 4 C) suggests that the role of IL-21 on Bε 
cells is to control cell growth and viability, rather than to 
regulate the diff  erentiation and maturation of these cells.
We found that expression of a proapoptotic gene, Bmf, 
was signifi  cantly higher in Bε cells than in Bγ cells (Fig. 5 A). 
Under physiological conditions, Bmf, which is a BH3 do-
main–only Bcl-2 family member that inhibits Bcl-2 function 
and accelerates apoptosis, binds to myosin V motors via the 
dynein light chain 2 domain of Bmf (34). In response to cer-
tain cellular damage signals, Bmf is supposed to be released 
from the myosin V motors and trigger apoptosis (34). Be-
cause Bmf from Bε cells induced apoptosis and a mutation in 
the BH3 domain of Bmf failed to induce apoptosis (Fig. S3), 
we confi  rmed that Bmf expressed in Bε cells is functional, 
and that the BH3 domain is important for the binding to Bcl-2 
and is essential for its proapoptotic activity. In fact, the bind-
ing of Bmf with Bcl-2 was up-regulated by IL-21R signaling 
(Fig. 5 C). Therefore, BCG-mediated Bε cell apoptosis is 
due to the augmented formation of Bmf–Bcl-2 complexes 
generated by IL-21R signaling in Bε cells.
Finally, we defi  ned the mechanism of BCG-induced 
IL-21–dependent suppression of IgE production in humans 
(Fig. 6). In a broader context, these fi  ndings may explain the 
mechanisms underlying the BCG-mediated suppression of 
allergic diseases and the epidemiological data indicating a re-
duction in the morbidity of allergic diseases in patients who JEM VOL. 203, December 25, 2006  2935
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have been infected with Mycobacterium tuberculosis. Interest-
ingly, IL-21–mediated B cell responses in C57BL/6 mice dif-
fer from those in BALB/c mice (26), suggesting that there is 
a genetic polymorphism with respect to the outcome of IL-21 
signaling in B cells. In fact, a recent report indicated that 
polymorphisms in the IL-21R gene locus diff  erentially aff  ect 
serum IgE levels in humans (47). In this study, consistent 
with our data, the levels of IL-21 expression induced by BCG 
stimulation varied among the individuals examined (Fig. 6 C). 
These results suggest that the response to BCG in humans 
is dependent, at least in part, on genetic background. The 
specifi  c genes responsible for the heterogeneity in BCG-
  mediated IL-21 production have not been identifi  ed. However, 
this observation may be applied to the development of diag-
nostic or therapeutic strategies in which the levels of IL-21 
expression are used to evaluate the effi   cacy of BCG treat-
ment, or in determining the potential benefi  t of therapy us-
ing bacterial products such as CpG for allergic diseases.
MATERIALS AND METHODS
Mice. 7–10-wk-old female BALB/c mice were purchased from Japan 
CREA Inc. Vα14 NKT-defi  cient (Vα14 NKT KO) mice on a BALB/c 
background (48), IRAK-4 KO (49), TLR2 KO, TLR4 KO, and MyD88 
KO mice (50, 51) have been described. TLR2 and TLR4 double KO 
mice were generated by breeding. Mice were kept under specifi  c pathogen-
free conditions, maintained on an OVA-free diet, and treated in accordance 
with the guidelines for animal care at RIKEN Research Center for Allergy 
and Immunology.
Allergic sensitization and BCG. Allergic epicutaneous sensitization was 
performed as described previously (27). In brief, a 1-cm2 sterile patch in-
fused with 100 μl of PBS solution with or without 100 μg OVA (grade V; 
Sigma-Aldrich) was placed on the shaved back of mice and fi  xed in place 
with a bio-occlusive dressing and an elastic bandage. Patches were left on for 
48 h and removed. The sensitization course was repeated at the same skin 
site every week for 4 wk. For BCG vaccination, mice were given a weekly 
i.p. injection of BCG (500 μg/mouse) or PBS at the time of OVA sensitiza-
tion. The attenuated BCG (strain Tokyo) was purchased from the Japan 
BCG Laboratory.
Flow cytometry. Cells were stained with antibodies after adding 2.4G2 
(BD Biosciences) for Fc blocking. The following antibodies were used: 
FITC–anti-CD19 (1D3), FITC–anti-IgE (R35-72), APC–anti-IgG1 (X59), 
FITC–anti-TCRβ (H57-597), APC–anti–IL-12p40/70 (C15.6), and 
PE–anti-CD11c (HL3; BD Biosciences). PE-conjugated α-GalCer–loaded 
CD1d tetramer (α-GalCer/CD1d tetramer) was prepared as described previ-
ously (52). For intracellular staining, BM-DCs were fi  xed and permeabilized 
with BD Cytofi  x and Cytoperm kits after staining with PE–anti-CD11c. 
They were then stained with APC–anti–IL-12p40/70. FACS analysis of at 
least 10,000 cells and cell sorting were performed with a FACSCalibur (BD 
Biosciences) with FlowJo software (TreeStar) or with a MoFlo cell sorter 
(DakoCytomation).
Cell preparations and cultures. 2 × 106 BM-DCs obtained by culturing 
BM for 6 d with 10 ng/ml GM-CSF were further cultured in the presence 
or absence of BCG, CpG, LPS (Invivogen), PGN from Escherichia coli 
  (Invivogen), or 10 μg/ml anti-CD3 mAb (2C11; BD Biosciences) for 48 h 
at 37°C. For blocking experiments, mAb against CD1d or IL-12p40/p70 
(clones 1B1 and C17.8, respectively; BD Biosciences), or an isotype control 
was added at a concentration of 20 μg/ml after 2.4G2 treatment. TCRβ+ 
cells or Vα14 NKT cells with a purity of >98% were obtained from liver 
MNCs (52) using an Auto MACS (Miltenyi Biotec) after staining with 
FITC–anti-TCRβ and sorting with anti-FITC magnetic beads (Miltenyi 
Biotec). Vα14 NKT cells were then isolated from TCRβ+ cells by MoFlo 
using PE–α-GalCer/CD1d tetramer. Conventional T or CD4+ T cells were 
isolated from an α-GalCer/CD1d tetramer− fraction of TCRβ+ liver 
MNCs. Bε and Bγ cells generated from splenic CD19+ cells in the presence 
of 10 μg/ml sCD40L (ALX-850-075; Qbiogene) and 20 ng/ml of recombi-
nant IL-4 (PeproTech) for 3 d (33) were cultured for 30 h for the apoptosis 
assay or for an additional 5 d to investigate IgE responses.
ELISA. Cytokines (IL-12p70 and IL-6) and Ig subclasses (IgG1, IgG2a, and 
IgE) were measured by ELISA using kits or sets of antibodies (BD Biosci-
ences) according to the manufacturer’s protocol. Specifi  c antibodies were 
also measured as described previously (7).
RT-PCR. Total RNA was extracted by RNAeasy (QIAGEN), and 
cDNA was synthesized with random primers after DNase treatment. The 
following RT-PCR primer sets were used for mouse genes: IL-21, 5′-
C  C  C  T  T  G  T  C  T  G  T  C  T  G  G  T  A  G  T  C  A  T  C  -3′ and 5′-A  T  C  A  C  A  G  G  A  A  G  G-
G  C  A  T  T  T  A  G  C  -3′; IgE (Cε), 5′-A  G  G  A  A  C  C  C  T  C  A  G  C  T  C  T  A  C  C  C  -3′ 
and 5′-G  C  C  A  G  C  T  G  A  C  A  G  A  G  A  C  A  T  C  A  -3′; mIL-21R, 5′-T  G  T  C  A  A  T-
G  T  G  A  C  G  G  A  C  C  A  G  T  -3′ and 5′-C  A  G  C  A  T  A  G  G  G  G  T  C  T  C  T  G  A  G  G  -3′; 
γc, 5′-G  T  C  G  A  C  A  G  A  G  C  A  A  G  C  A  C  C  A  T  G  T  T  G  A  A  A  C  T  A  -3′ and 5′-G  G  A-
T  C  C  T  G  G  G  A  T  C  A  C  A  A  G  A  T  T  C  T  G  T  A  G  G  T  T  -3′; Bmf, 5′-C  A  G  A  C  C  C-
T  C  A  G  T  C  C  A  G  C  T  T  C  -3′ and 5′-C  G  T  A  T  G  A  A  G  C  C  G  A  T  G  G  A  A  C  T  -3′; 
Bcl-2, 5′-G  G  T  G  G  T  G  G  A  G  G  A  A  C  T  C  T  T  C  A  -3′ and 5′-C  A  T  G  C  T  G  G  G  G-
C  C  A  T  A  T  A  G  T  T  -3′; and HPRT, 5′-A  G  C  G  T  C  G  T  G  A  T  T  A  G  C  G  A  T  G  -3′ 
and 5′-C  T  T  T  T  A  T  G  T  C  C  C  C  C  G  T  T  G  A  C  -3′. The numbers of PCR cycles 
were as follows: 30 for HPRT; 35 for IgE, γc, and IL-21R; 40 for IL-21 
and Bmf; and 45 for Bcl-2. The amounts of cDNA were standardized by 
quantifi  cation of the housekeeping gene HPRT using primers for mouse 
samples. The human IL-21 mRNA levels were quantifi   ed by real-time 
quantitative PCR on the ABI Prism 7000 sequence detection system 
  (Applied Biosystems) by using TaqMan assay kits and TaqMan Gene Expression 
Assays (primers and TaqMan probes).
Electrophoretic mobility shift assay. 2 × 106 BM-DCs were stimulated 
with 50 μg/ml BCG or 1.0 μM CpG-B for the indicated periods. Nuclear 
extracts were prepared and used for Gel Shift Assay Systems (Promega) as 
described previously (50).
B𝗆 cell–derived Bmf and its mutants. cDNAs encoding bmf were amplifi  ed 
from Bε cells by PCR using primers 5′-C  C  G  A  A  T  T  C  G  G  A  T  G  G  A  G  C  C  A  C  C  T-
C  A  G  T  G  T  G  T  -3′ and 5′-G  C  G  G  C  C  G  C  C  T  G  C  A  T  T  C  C  T  G  G  T  G  A  T  C  C  A  T  -
3′ (EcoRI and NotI sites for cloning are underlined). The amplifi  ed products 
were cloned using the pGEM-T Easy Vector System (Promega). Mutant 
cDNAs were generated by PCR using point-mutated primer pairs.
Immunoprecipitation and Western blotting. Interaction of Bmf with 
Bcl-2 in Bε cells was detected by immunoprecipitation with anti–Bcl-2 
mAb (clone 7; BD Transduction Laboratories) and subsequent immunoblot-
ting with anti-Bmf rabbit antibody (Cell Signaling). The protein levels were 
visualized by ECL (GE Healthcare) using horseradish peroxidase–conjugated 
Protein A/G (Pierce Chemical Co.).
Human studies. All human specimens were obtained under informed consent. 
The protocol for the human research project has been approved by the 
  Ethics Committee of Chiba University and RIKEN, and conformed to the 
provisions of the Declaration of Helsinki in 1995. 108 PBMCs from healthy 
volunteers were prepared by Ficoll-Paque density gradient centrifugation 
and used for the cultures. Human recombinant IL-21 was purchased from 
BIOSOURCE Inc. Human total IgE was measured with a sensitive immune 
assay (GE Healthcare).
Statistical analysis. Statistical analyses were performed using the Student’s 
t test or matched pairs t test. P < 0.05 was considered statistically signifi  cant.2936  IL-21–DEPENDENT Bε CELL APOPTOSIS MEDIATED BY NKT CELLS | Harada et al.
Online supplemental material. Fig. S1 provides data demonstrat-
ing that MyD88 signaling in DCs is required for BCG-induced activa-
tion. Fig. S2 contains data demonstrating IL-21 mRNA expression by 
NKT cells, CD4+ T cells, and CD8+ T cells of murine and human ori-
gin. Fig. S3 provides the data indicating proapoptotic activity of Bε cell–
derived Bmf and functional domain analysis using mutant Bmf in Baf3 
cells. The online supplemental material is available at http://www.jem.
org/cgi/content/full/jem.20062206/DC1.
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